PI (Principal Investigator)
Prof. Reinhard Dummer
Laufende Studie
Merkelzellkarzinom: A Phase 2 Study of a Anti-PD-1 Monoclonal Antibody (INCMGA00012) in Participants With Metastatic Merkel Cell Carcinoma
Stadium/Indikation inkl. Kurzinfo
Merkelzellkarzinom
Nicht vorbehandeltes Metastasiertes MCC
anti-PD1 Therapie
Kurztitel
INCMGA 0012-201
NCT03599713
Offizieller Titel
A Phase 2 Study of a Anti-PD-1 Monoclonal Antibody (INCMGA00012) in Participants With Metastatic Merkel Cell Carcinoma